Godrej Industries Q4 FY26 Profit Soars 143% to ₹444 Crore on Strong Performance
Godrej Industries Limited reported a 143% surge in consolidated net profit to ₹444 crore for Q4 FY26, driven by strong performances across its subsidiaries. Total income rose 29% to ₹8,274 crore. Godrej Properties achieved record quarterly bookings of ₹10,163 crore. Godrej Consumer Products and Godrej Agrovet also posted robust growth.
The substantial increase in net profit and strong performance across major business segments like consumer goods, chemicals, real estate, and agribusiness suggests a significant positive impact on the company's overall financial health and market standing.
The company reported significant year-on-year growth in total income and net profit, alongside strong performance indicators from its key subsidiaries, indicating a positive financial outcome.
Godrej Industries Limited announced its audited financial results for the quarter and financial year ended March 31, 2026. The Board of Directors approved these results on May 15, 2026.
Consolidated total income for the fourth quarter of FY26 grew by 29% to ₹8,274 crore from ₹6,400 crore in Q4 FY25. PBDIT (Profit Before Depreciation, Interest, and Taxes) saw a significant increase of 51% to ₹1,950 crore. Net profit after tax experienced a substantial surge of 143%, reaching ₹444 crore in Q4 FY26 compared to ₹183 crore in the same period last year. For the full financial year 2026, consolidated total income increased by 19% to ₹25,981 crore, and net profit grew by 26% to ₹1,241 crore from ₹981 crore in FY25.
The company's subsidiaries also reported strong performance. Godrej Consumer Products (GCPL) saw a 11% year-on-year growth in consolidated sales and a 10% growth in net profit for Q4 FY26. The Chemicals business reported a 16% increase in revenue for Q4 FY26 and a 22% increase for FY26. Godrej Properties Limited (GPL) achieved its highest ever quarterly bookings in Q4 FY26 at ₹10,163 crore, a 21% increase quarter-on-quarter, contributing to a 16% YoY growth in booking value for FY26 to ₹34,171 crore. Godrej Agrovet Limited (GAVL) experienced accelerated, broad-based volume growth of approximately 15% in Animal Nutrition for Q4 FY26.
What to do with a filing like this
Godrej Industries Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Godrej Industries Limited. Read the original for the full detail.